Managing acute mesenteric ischaemia

Abstract

Acute mesenteric ischaemia (AMI) is a condition where different etiopathogenetic pathways may lead to necrosis of the bowel and thereby to lethal outcome. Despite the common threat of intestinal necrosis, different subtypes of AMI (occlusive arterial, occlusive venous and nonocclusive) have variable incidence, are managed differently and lead to different outcomes [1]. In this article, we summarize recent evidence related to diagnosis, management and outcomes of AMI.

Non-occlusive mesenteric ischemia and intra-arterial vasodilatory therapy in severe shock and multi-organ failure: treating the untreatable?

“…With great interest we read the recent article by Reintam Blaser et al describing the current status of managing acute mesenteric ischemia (AMI) in the critically ill patient [ 1 ]. We would like to congratulate the authors for their thorough and balanced review of the present diagnostic and therapeutic options in these patients and especially agree on the importance of further research in exploring the least understood AMI entity associated with the highest mortality, namely non-occlusive mesenteric ischemia (NOMI).…”